Nvidia takes minority stakes in four French startups, including Doctolib and Genesis AI, ahead of a $2 billion European plan

NVDA is buying minority stakes in four French technology startups: health-booking platform Doctolib, robotics developer Genesis AI, business-planning software maker Pigment and Entalpic, which uses generative AI for materials discovery. Les Echos first reported the four deals. Doctolib and Genesis AI confirmed them, with Genesis AI calling Nvidia a strategic investor, while Pigment and Entalpic had not responded to requests for comment. No amounts were disclosed.

Chief executive Jensen Huang said Nvidia will announce $2 billion in new European investments next week, without saying what form they will take. The French stakes add to a growing portfolio: Nvidia's long-term investments on its balance sheet stood at $51.16 billion, up from $3.80 billion a year earlier.

In a separate announcement, Nvidia pledged a five-year compute donation to the United Kingdom valued at $250 million, or about $50 million a year of access, for research on agentic AI safety and security. The compute will run through UK-based Nvidia cloud partners, with provider and commercial terms still to be agreed. It is access to computing capacity, not cash.

The common thread is Nvidia using its balance sheet to seed demand for its platform in Europe, through equity in AI application companies and subsidized compute for researchers. Next week's $2 billion announcement should show whether that strategy extends to infrastructure or stays focused on startup stakes.